{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T18:49:32Z","timestamp":1790362172458,"version":"4.1.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s11010-025-05218-x","type":"journal-article","created":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T03:02:58Z","timestamp":1740798178000},"page":"4119-4134","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["SOX11 exacerbates ferroptosis to reduce lenvatinib resistance in liver cancer cells by promoting ubiquitination degradation of SREBF1 through upregulating UBE3A"],"prefix":"10.1007","volume":"480","author":[{"given":"Zushun","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisong","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,1]]},"reference":[{"issue":"3","key":"5218_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H et al (2021) Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 Countries. CA Cancer J Clin 71(3):209\u2013249","journal-title":"CA Cancer J Clin"},{"issue":"10127","key":"5218_CR2","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0140-6736(18)30010-2","volume":"391","author":"A Forner","year":"2018","unstructured":"Forner A, Reig M, Bruix J (2018) Hepatocellular carcinoma. Lancet 391(10127):1301\u20131314","journal-title":"Lancet"},{"issue":"1","key":"5218_CR3","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/s41420-023-01597-6","volume":"9","author":"K Tian","year":"2023","unstructured":"Tian K et al (2023) Sophoridine derivative 6j inhibits liver cancer cell proliferation via ATF3 mediated ferroptosis. Cell Death Discov 9(1):296","journal-title":"Cell Death Discov"},{"key":"5218_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2019.114428","volume":"460","author":"S Chen","year":"2019","unstructured":"Chen S et al (2019) Targeted therapy for hepatocellular carcinoma: challenges and opportunities. Cancer Lett 460:1\u20139","journal-title":"Cancer Lett"},{"key":"5218_CR5","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.2147\/JHC.S411806","volume":"10","author":"M Tao","year":"2023","unstructured":"Tao M et al (2023) Application and resistance mechanisms of lenvatinib in patients with advanced hepatocellular carcinoma. J Hepatocell Carcinoma 10:1069\u20131083","journal-title":"J Hepatocell Carcinoma"},{"issue":"4","key":"5218_CR6","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","volume":"22","author":"X Jiang","year":"2021","unstructured":"Jiang X, Stockwell BR, Conrad M (2021) Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol 22(4):266\u2013282","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"5","key":"5218_CR7","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41571-020-00462-0","volume":"18","author":"X Chen","year":"2021","unstructured":"Chen X et al (2021) Broadening horizons: the role of ferroptosis in cancer. Nat Rev Clin Oncol 18(5):280\u2013296","journal-title":"Nat Rev Clin Oncol"},{"issue":"7","key":"5218_CR8","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.1111\/cas.15378","volume":"113","author":"N Iseda","year":"2022","unstructured":"Iseda N et al (2022) Ferroptosis is induced by lenvatinib through fibroblast growth factor receptor-4 inhibition in hepatocellular carcinoma. Cancer Sci 113(7):2272\u20132287","journal-title":"Cancer Sci"},{"key":"5218_CR9","doi-asserted-by":"publisher","first-page":"1153991","DOI":"10.3389\/fphar.2023.1153991","volume":"14","author":"W Bo","year":"2023","unstructured":"Bo W, Chen Y (2023) Lenvatinib resistance mechanism and potential ways to conquer. Front Pharmacol 14:1153991","journal-title":"Front Pharmacol"},{"issue":"2","key":"5218_CR10","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/s41418-020-00708-5","volume":"28","author":"PE Cockram","year":"2021","unstructured":"Cockram PE et al (2021) Ubiquitination in the regulation of inflammatory cell death and cancer. Cell Death Differ 28(2):591\u2013605","journal-title":"Cell Death Differ"},{"key":"5218_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24098441","author":"SY Koo","year":"2023","unstructured":"Koo SY et al (2023) Ubiquitination links DNA damage and repair signaling to cancer metabolism. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms24098441","journal-title":"Int J Mol Sci"},{"issue":"2","key":"5218_CR12","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/s41418-021-00862-4","volume":"29","author":"C Ren","year":"2022","unstructured":"Ren C et al (2022) Ubiquitination of NF-\u03baB p65 by FBXW2 suppresses breast cancer stemness, tumorigenesis, and paclitaxel resistance. Cell Death Differ 29(2):381\u2013392","journal-title":"Cell Death Differ"},{"issue":"27","key":"5218_CR13","doi-asserted-by":"publisher","first-page":"e2302025","DOI":"10.1002\/advs.202302025","volume":"10","author":"Y Liao","year":"2023","unstructured":"Liao Y et al (2023) HSP90\u03b2 impedes STUB1-induced ubiquitination of YTHDF2 to drive sorafenib resistance in hepatocellular carcinoma. Adv Sci (Weinh) 10(27):e2302025","journal-title":"Adv Sci (Weinh)"},{"key":"5218_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12082108","author":"A Owais","year":"2020","unstructured":"Owais A, Mishra RK, Kiyokawa H (2020) The HECT E3 Ligase E6AP\/UBE3A as a therapeutic target in cancer and neurological disorders. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers12082108","journal-title":"Cancers (Basel)"},{"issue":"6","key":"5218_CR15","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/0092-8674(90)90409-8","volume":"63","author":"M Scheffner","year":"1990","unstructured":"Scheffner M et al (1990) The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63(6):1129\u20131136","journal-title":"Cell"},{"issue":"2","key":"5218_CR16","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.bbagrm.2010.08.011","volume":"1809","author":"S Srinivasan","year":"2011","unstructured":"Srinivasan S, Nawaz Z (2011) E3 ubiquitin protein ligase, E6-associated protein (E6-AP) regulates PI3K-Akt signaling and prostate cell growth. Biochim Biophys Acta 1809(2):119\u2013127","journal-title":"Biochim Biophys Acta"},{"key":"5218_CR17","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.aaf8223","author":"C Gamell","year":"2017","unstructured":"Gamell C et al (2017) Reduced abundance of the E3 ubiquitin ligase E6AP contributes to decreased expression of the INK4\/ARF locus in non-small cell lung cancer. Sci Signal. https:\/\/doi.org\/10.1126\/scisignal.aaf8223","journal-title":"Sci Signal"},{"issue":"4","key":"5218_CR18","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/s41419-022-04760-6","volume":"13","author":"W Liu","year":"2022","unstructured":"Liu W et al (2022) The RBPJ\/DAPK3\/UBE3A signaling axis induces PBRM1 degradation to modulate the sensitivity of renal cell carcinoma to CDK4\/6 inhibitors. Cell Death Dis 13(4):295","journal-title":"Cell Death Dis"},{"issue":"1","key":"5218_CR19","doi-asserted-by":"publisher","first-page":"4362","DOI":"10.1038\/s41467-021-24656-x","volume":"12","author":"LY Li","year":"2021","unstructured":"Li LY et al (2021) Interplay and cooperation between SREBF1 and master transcription factors regulate lipid metabolism and tumor-promoting pathways in squamous cancer. Nat Commun 12(1):4362","journal-title":"Nat Commun"},{"issue":"4","key":"5218_CR20","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1158\/0008-5472.CAN-22-2156","volume":"83","author":"GC Zhang","year":"2023","unstructured":"Zhang GC et al (2023) PRP19 enhances esophageal squamous cell carcinoma progression by reprogramming SREBF1-dependent fatty acid metabolism. Cancer Res 83(4):521\u2013537","journal-title":"Cancer Res"},{"issue":"1","key":"5218_CR21","doi-asserted-by":"publisher","first-page":"210","DOI":"10.3892\/ol.2022.13331","volume":"24","author":"X Zhang","year":"2022","unstructured":"Zhang X et al (2022) ApoM regulates PFKL through the transcription factor SREBF1 to inhibit the proliferation, migration and metastasis of liver cancer cells. Oncol Lett 24(1):210","journal-title":"Oncol Lett"},{"issue":"10","key":"5218_CR22","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1038\/onc.2014.44","volume":"34","author":"PY Kuo","year":"2015","unstructured":"Kuo PY et al (2015) High-resolution chromatin immunoprecipitation (ChIP) sequencing reveals novel binding targets and prognostic role for SOX11 in mantle cell lymphoma. Oncogene 34(10):1231\u20131240","journal-title":"Oncogene"},{"issue":"7","key":"5218_CR23","doi-asserted-by":"publisher","first-page":"e2306298","DOI":"10.1002\/advs.202306298","volume":"11","author":"Y Cao","year":"2024","unstructured":"Cao Y et al (2024) BHLHE40 inhibits ferroptosis in pancreatic cancer cells via upregulating SREBF1. Adv Sci (Weinh) 11(7):e2306298","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"5218_CR24","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1097\/MCD.0000000000000348","volume":"30","author":"V Wakim","year":"2021","unstructured":"Wakim V et al (2021) SOX11-related syndrome: report on a new case and review. Clin Dysmorphol 30(1):44\u201349","journal-title":"Clin Dysmorphol"},{"key":"5218_CR25","doi-asserted-by":"publisher","first-page":"e16593","DOI":"10.7717\/peerj.16593","volume":"11","author":"S Li","year":"2023","unstructured":"Li S et al (2023) Inhibition of hepatocellular carcinoma growth via modulation of the miR-221\/SOX11 axis by curcumin and berberine. PeerJ 11:e16593","journal-title":"PeerJ"},{"issue":"11","key":"5218_CR26","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1007\/s13258-022-01240-1","volume":"44","author":"Y Huang","year":"2022","unstructured":"Huang Y et al (2022) SOX11-dependent CATSPER1 expression controls colon cancer cell growth through regulation the PI3K\/AKT signaling pathway. Genes Genomics 44(11):1415\u20131424","journal-title":"Genes Genomics"},{"issue":"10","key":"5218_CR27","doi-asserted-by":"publisher","first-page":"e8631","DOI":"10.1590\/1414-431x20198631","volume":"52","author":"Z Liu","year":"2019","unstructured":"Liu Z et al (2019) lncRNA MEG3 inhibits the growth of hepatocellular carcinoma cells by sponging miR-9-5p to upregulate SOX11. Braz J Med Biol Res 52(10):e8631","journal-title":"Braz J Med Biol Res"},{"issue":"2","key":"5218_CR28","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1002\/bab.1718","volume":"66","author":"Z Liu","year":"2019","unstructured":"Liu Z et al (2019) SOX11 regulates apoptosis and cell cycle in hepatocellular carcinoma via Wnt\/\u03b2-catenin signaling pathway. Biotechnol Appl Biochem 66(2):240\u2013246","journal-title":"Biotechnol Appl Biochem"},{"issue":"20","key":"5218_CR29","doi-asserted-by":"publisher","first-page":"17901","DOI":"10.1074\/jbc.M212211200","volume":"278","author":"MS Wiebe","year":"2003","unstructured":"Wiebe MS, Nowling TK, Rizzino A (2003) Identification of novel domains within Sox-2 and Sox-11 involved in autoinhibition of DNA binding and partnership specificity. J Biol Chem 278(20):17901\u201317911","journal-title":"J Biol Chem"},{"issue":"1","key":"5218_CR30","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1158\/0008-5472.CAN-22-0963","volume":"83","author":"M Huang","year":"2023","unstructured":"Huang M et al (2023) METTL1-mediated m7G tRNA modification promotes lenvatinib resistance in hepatocellular carcinoma. Cancer Res 83(1):89\u2013102","journal-title":"Cancer Res"},{"key":"5218_CR31","doi-asserted-by":"publisher","first-page":"100916","DOI":"10.1016\/j.drup.2022.100916","volume":"66","author":"Y Wang","year":"2023","unstructured":"Wang Y et al (2023) Overcoming cancer chemotherapy resistance by the induction of ferroptosis. Drug Resist Updat 66:100916","journal-title":"Drug Resist Updat"},{"issue":"12","key":"5218_CR32","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1002\/mc.23625","volume":"62","author":"A Buttell","year":"2023","unstructured":"Buttell A, Qiu W (2023) The action and resistance mechanisms of Lenvatinib in liver cancer. Mol Carcinog 62(12):1918\u20131934","journal-title":"Mol Carcinog"},{"issue":"1","key":"5218_CR33","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1159\/000504624","volume":"9","author":"A Alsina","year":"2020","unstructured":"Alsina A et al (2020) Effects of subsequent systemic anticancer medication following first-line lenvatinib: a post hoc responder analysis from the Phase 3 REFLECT study in unresectable hepatocellular carcinoma. Liver Cancer 9(1):93\u2013104","journal-title":"Liver Cancer"},{"issue":"1","key":"5218_CR34","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12943-022-01530-y","volume":"21","author":"C Zhang","year":"2022","unstructured":"Zhang C et al (2022) Ferroptosis in cancer therapy: a novel approach to reversing drug resistance. Mol Cancer 21(1):47","journal-title":"Mol Cancer"},{"key":"5218_CR35","doi-asserted-by":"publisher","DOI":"10.2174\/0115680096279597240219055135","author":"Z Song","year":"2024","unstructured":"Song Z et al (2024) HAND2-AS1 promotes ferroptosis to reverse lenvatinib resistance in hepatocellular carcinoma by TLR4\/NOX2\/DUOX2 Axis. Curr Cancer Drug Targets. https:\/\/doi.org\/10.2174\/0115680096279597240219055135","journal-title":"Curr Cancer Drug Targets"},{"issue":"12","key":"5218_CR36","doi-asserted-by":"publisher","first-page":"3024","DOI":"10.7150\/ijbs.61117","volume":"17","author":"Z Zheng","year":"2021","unstructured":"Zheng Z et al (2021) UBE3A activates the NOTCH pathway and promotes esophageal cancer progression by degradation of ZNF185. Int J Biol Sci 17(12):3024\u20133035","journal-title":"Int J Biol Sci"},{"issue":"1","key":"5218_CR37","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/s41420-023-01499-7","volume":"9","author":"J Gan","year":"2023","unstructured":"Gan J et al (2023) MicroRNA-375 restrains the progression of lung squamous cell carcinoma by modulating the ERK pathway via UBE3A-mediated DUSP1 degradation. Cell Death Discov 9(1):199","journal-title":"Cell Death Discov"},{"issue":"12","key":"5218_CR38","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1038\/nrendo.2017.91","volume":"13","author":"H Shimano","year":"2017","unstructured":"Shimano H, Sato R (2017) SREBP-regulated lipid metabolism: convergent physiology - divergent pathophysiology. Nat Rev Endocrinol 13(12):710\u2013730","journal-title":"Nat Rev Endocrinol"},{"issue":"20","key":"5218_CR39","doi-asserted-by":"publisher","first-page":"8117","DOI":"10.1158\/0008-5472.CAN-09-3871","volume":"70","author":"E Rysman","year":"2010","unstructured":"Rysman E et al (2010) De novo lipogenesis protects cancer cells from free radicals and chemotherapeutics by promoting membrane lipid saturation. Cancer Res 70(20):8117\u20138126","journal-title":"Cancer Res"},{"key":"5218_CR40","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.canlet.2019.11.032","volume":"470","author":"M Zhao","year":"2020","unstructured":"Zhao M et al (2020) SPIN1 triggers abnormal lipid metabolism and enhances tumor growth in liver cancer. Cancer Lett 470:54\u201363","journal-title":"Cancer Lett"},{"key":"5218_CR41","doi-asserted-by":"publisher","first-page":"125854","DOI":"10.1016\/j.ijbiomac.2023.125854","volume":"248","author":"X Zhang","year":"2023","unstructured":"Zhang X et al (2023) Minichromosome maintenance protein family member 6 mediates hepatocellular carcinoma progression by recruiting UBE3A to induce P53 ubiquitination. Int J Biol Macromol 248:125854","journal-title":"Int J Biol Macromol"},{"key":"5218_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14246103","author":"Q Sun","year":"2022","unstructured":"Sun Q et al (2022) Systematic investigation of the multifaceted role of SOX11 in cancer. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers14246103","journal-title":"Cancers (Basel)"},{"issue":"1","key":"5218_CR43","doi-asserted-by":"publisher","first-page":"248","DOI":"10.21037\/tcr.2019.01.27","volume":"8","author":"FW Wang","year":"2019","unstructured":"Wang FW, Ao X, Fu SM (2019) Expression of SOX11 and HER2 and their association with recurrent breast cancer. Transl Cancer Res 8(1):248\u2013254","journal-title":"Transl Cancer Res"},{"issue":"8","key":"5218_CR44","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1016\/j.ejca.2009.01.028","volume":"45","author":"DJ Brennan","year":"2009","unstructured":"Brennan DJ et al (2009) The transcription factor Sox11 is a prognostic factor for improved recurrence-free survival in epithelial ovarian cancer. Eur J Cancer 45(8):1510\u20131517","journal-title":"Eur J Cancer"},{"issue":"13","key":"5218_CR45","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.7150\/jca.24797","volume":"9","author":"H Sun","year":"2018","unstructured":"Sun H et al (2018) Aberrant methylation of FAT4 and SOX11 in peripheral blood leukocytes and their association with gastric cancer risk. J Cancer 9(13):2275\u20132283","journal-title":"J Cancer"},{"issue":"1","key":"5218_CR46","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s13046-019-1146-7","volume":"38","author":"J Huang","year":"2019","unstructured":"Huang J et al (2019) Sox11 promotes head and neck cancer progression via the regulation of SDCCAG8. J Exp Clin Cancer Res 38(1):138","journal-title":"J Exp Clin Cancer Res"},{"issue":"4","key":"5218_CR47","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1182\/blood-2017-04-776740","volume":"130","author":"P Balsas","year":"2017","unstructured":"Balsas P et al (2017) SOX11 promotes tumor protective microenvironment interactions through CXCR4 and FAK regulation in mantle cell lymphoma. Blood 130(4):501\u2013513","journal-title":"Blood"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-025-05218-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-025-05218-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-025-05218-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T07:24:27Z","timestamp":1757143467000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-025-05218-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,1]]},"references-count":47,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["5218"],"URL":"https:\/\/doi.org\/10.1007\/s11010-025-05218-x","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,1]]},"assertion":[{"value":"8 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All patients have signed informed consent forms, and this study has been approved by the ethics committee of Guangxi Medical University Cancer Center. The animal studies were approved by Guangxi Medical University Cancer Center.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"The informed consent was obtained from study participants.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}